{"id":"W4412156955","doi":"10.1200/jco-25-01346","title":"RP1 Combined With Nivolumab in Advanced Anti–PD-1–Failed Melanoma (IGNYTE)","year":2025,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":35,"is_retracted":false,"has_abstract":true,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Medicine; Nivolumab; Melanoma; Metastatic melanoma; Oncology; Ipilimumab; Internal medicine; Cancer research; Immunotherapy; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007676621,0.0003728793,0.0008318393,0.0003153578,0.0001405748,0.0003303615,0.0002691415,0.0002100915,0.000945384],"category_scores_gemma":[0.0004132838,0.0001632628,0.0005220578,0.0001547895,0.0002003322,0.0002190338,0.0002182127,0.0006356246,0.0002858769],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004634963,"about_ca_system_score_gemma":0.000256613,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004523184,"about_ca_topic_score_gemma":0.001066428,"domain_scores_codex":[0.999674,0.0001486994,0.0000219506,0.0000514223,0.00005337143,0.00005062526],"domain_scores_gemma":[0.9998296,0.00004030248,0.00004644945,0.00001662281,0.00001077529,0.00005619939],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.1108971,0.01238063,0.04165439,0.002139381,0.002154181,0.002260929,0.0004230946,0.007561909,0.1771198,0.0005718737,0.003307169,0.6395296],"study_design_scores_gemma":[0.02789881,0.6766503,0.1552251,0.0003882595,0.001927677,0.006766858,0.000220872,0.01348692,0.0900773,0.0004357915,0.02684186,0.00008027859],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9922828,0.005476115,0.0004050453,0.0001011055,0.00004648163,0.0001271083,0.00009110083,0.00004882893,0.001421427],"genre_scores_gemma":[0.9979815,0.001064226,0.0003061066,0.00005716563,0.00003137444,0.00003839888,0.0000974299,0.00000630316,0.0004173876],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.000945384,"threshold_uncertainty_score":0.004059851,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03912793746815623,"score_gpt":0.4373174219530394,"score_spread":0.3981894844848832,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}